Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

VRTX | NASDAQ
Chart Builder DCF Calculator
$553.15
-$5.73 (-1.03%)
At close: Nov 2, 2026, 4:00 PM ET
$553.64
+$0.49 (+0.09%)
After-hours: Nov 2, 2026, 4:39 PM ET
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Cash & Equivalents
6.14B 5.49B 5.09B 4.94B 4.97B 4.67B 4.57B 5.24B 4.58B 9.16B 10.37B 11.11B 10.15B 9.29B 10.5B 9.17B 8.7B 7.6B 6.8B 6.28B 6.06B 6.3B
Short-Term Investments
1.71B 1.75B 1.52B 1.35B 1.41B 1.53B 1.55B 1.29B 1.22B 1.01B 849.2M 818M 1.09B 1.12B 274.5M 599.2M 551.2M 638M 729.9M 685.19M 644.32M 619.64M
Long-Term Investments
5.79B 5.75B 5.81B 5.72B 5.65B 5.16B 5.11B 4.7B 4.39B 4.38B 2.5B 1.7B 1.36B 1.08B 112.2M 107.7M 102.7M 86.7M n/a 35.9M n/a n/a
Other Long-Term Assets
1.25B 2.94B 1.14B 1.1B 1.08B 1.01B 999.3M 990.2M 915.6M 875.7M 895.3M 475.2M 442.7M 427.5M 409.6M 24.8M 24.6M 24M 110.8M 39.62M 71.1M 49.26M
Receivables
2.13B 2B 2.05B 1.95B 1.89B 1.81B 1.61B 1.75B 1.66B 1.79B 1.56B 1.54B 1.56B 1.55B 1.44B 1.39B 1.33B 1.29B 1.14B 1.1B 929.14M 977.55M
Inventory
1.77B 1.77B 1.69B 1.63B 1.5B 1.36B 1.21B 1.08B 914.6M 813.1M 738.8M 688.7M 603.5M 535.1M 460.6M 388.2M 367.7M 338.9M 353.1M 333.46M 321.62M 298.86M
Other Current Assets
n/a 720.8M 748.6M 709.4M 652.3M 642.8M 206.5M 449.2M 575.4M 511.1M 86.1M 540.2M 476.9M 468.7M 121.9M 197.1M 120.8M 61.1M 103.7M 38.82M n/a 15.62M
Total Current Assets
12.54B 11.73B 11.2B 10.57B 10.43B 10.01B 9.6B 9.8B 8.94B 13.29B 14.14B 14.7B 13.87B 12.97B 13.23B 12.27B 11.5B 10.36B 9.56B 8.85B 8.46B 8.54B
Property-Plant & Equipment
3.33B 1.61B 3.08B 3.02B 2.65B 2.63B 2.58B 2.51B 1.77B 1.49B 1.45B 1.43B 1.45B 1.45B 1.46B 1.46B 1.42B 1.44B 1.42B 1.35B 1.34B 1.31B
Goodwill & Intangibles
1.5B 1.51B 1.51B 1.52B 1.52B 1.53B 1.91B 1.92B 1.93B 1.92B 1.93B 1.69B 1.69B 1.69B 1.69B 1.68B 1.39B 1.4B 1.4B 1.4B 1.4B 1.4B
Total Long-Term Assets
14.88B 14.75B 14.94B 14.29B 13.61B 12.87B 12.94B 12.44B 11.19B 10.63B 8.59B 7.03B 6.48B 6.01B 4.92B 4.44B 4.08B 3.89B 3.87B 3.77B 3.76B 3.58B
Total Assets
27.42B 26.48B 26.14B 24.86B 24.04B 22.88B 22.53B 22.24B 20.13B 23.92B 22.73B 21.73B 20.35B 18.97B 18.15B 16.71B 15.58B 14.26B 13.43B 12.62B 12.22B 12.12B
Account Payables
429.5M 489.3M 461.7M 420.3M 442.3M 445M 413M 395.8M 327.9M 351.4M 364.9M 375.9M 363M 323.2M 303.9M 126.9M 198M 173.6M 195M 127.86M 127.53M 127.84M
Deferred Revenue
n/a n/a 171.8M n/a n/a n/a 206.8M n/a n/a n/a 170.3M n/a n/a n/a 159.6M n/a n/a n/a 171.7M n/a n/a n/a
Short-Term Debt
n/a n/a 82.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
329.4M 407.1M 2.75B 441.5M 425.4M 386.4M 31.4M 357.6M 279.3M 648.6M 50.7M 316.2M 391M 377M 62.5M 218M 238.7M 286.1M 16.5M 201.41M 226.36M 284.17M
Total Current Liabilities
3.94B 3.88B 3.86B 4.48B 4.14B 3.78B 3.56B 3.97B 3.55B 3.8B 3.55B 3.6B 3.35B 3.03B 2.74B 2.61B 2.56B 2.18B 2.14B 1.91B 1.84B 1.94B
Long-Term Debt
n/a n/a 1.85B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
3.24B 1.26B -1.49B 1.23B 1.2B 951.9M 901.8M 933.3M 876.8M 853.6M 877.7M 869.3M 759.3M 726.5M 685.8M 242.9M 245.2M 296.4M 303.3M 296.97M 294.99M 291.96M
Total Long-Term Liabilities
3.24B 3.24B 3.62B 3.07B 2.72B 2.6B 2.56B 2.64B 1.81B 1.57B 1.6B 1.61B 1.53B 1.52B 1.5B 1.07B 1.09B 1.17B 1.19B 1.17B 1.19B 1.19B
Total Liabilities
7.18B 7.12B 7.48B 7.54B 6.86B 6.38B 6.12B 6.61B 5.36B 5.37B 5.15B 5.21B 4.88B 4.54B 4.24B 3.68B 3.65B 3.35B 3.33B 3.09B 3.03B 3.13B
Total Debt
n/a 1.99B 3.88B 1.83B 1.53B 1.65B 1.75B 1.7B 933.4M 721.3M 808.4M 744.7M 767.6M 789.2M 899.7M 824.6M 847.3M 872.5M 967.4M 876.8M 893.85M 898.8M
Book Value
20.25B 19.36B 18.67B 17.32B 17.18B 16.5B 16.41B 15.63B 14.77B 18.55B 17.58B 16.51B 15.47B 14.43B 13.91B 13.03B 11.93B 10.91B 10.1B 9.53B 9.2B 8.98B
Book Value Per Share
79.19 75.54 72.88 67.23 66.34 63.57 62.99 59.89 57.24 71.03 67.38 63.36 59.41 55.44 53.45 50.21 46.13 42.29 39.30 36.70 35.23 34.29
Common Stock
2.5M 2.5M 2.5M 2.5M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.5M 2.56M 2.59M 2.59M
Retained Earnings
15.69B 14.59B 13.56B 12.37B 11.29B 10.25B 9.61B 8.69B 7.65B 11.24B 10.14B 9.17B 8.14B 7.22B 6.52B 5.7B 4.77B 3.96B 3.2B 2.43B 1.58B 1.51B
Comprehensive Income
48.5M 24.8M -15.9M -64.5M -101.1M 68.1M 127.8M 28.8M 22.5M 17.3M -14.3M -3M -39.8M -13.1M 800K 97.6M 57.5M 11.3M 15.9M 11.54M -25.16M -33.3M
Shareholders Equity
20.25B 19.36B 18.67B 17.32B 17.18B 16.5B 16.41B 15.63B 14.77B 18.55B 17.58B 16.51B 15.47B 14.43B 13.91B 13.03B 11.93B 10.91B 10.1B 9.53B 9.2B 8.98B
Total Investments
7.5B 7.5B 7.33B 7.07B 7.06B 6.68B 6.65B 5.99B 5.61B 5.39B 3.35B 2.52B 2.44B 2.21B 386.7M 706.9M 653.9M 724.7M 729.9M 721.09M 644.32M 619.64M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.